Abstract:Key PointsAtherothrombotic vascular disease (ATVD) is the leading cause of death in the industrialized world, and this problem is growing owing to the increase in obesity and insulin resistance worldwide. ATVD develops as a macrophage-dominant maladaptive inflammatory response to subendothelial lipoproteins.A fundamental aspect of this maladaptive inflammatory response is a failure to resolve inflammation, which normally involves the suppression of inflammatory cell influx, effective phagocytic clearance of apoptotic cells and promotion of inflammatory cell egress. The mechanism of failed inflammation resolution in atherosclerosis is not known, but it is likely to involve defective generation or action of anti-inflammatory cytokines (for example, interleukin-10), pro-resolution lipid mediators (for example, lipoxins) and transcription factors (for example, the liver X receptor family) that normally carry out this process.In advanced atherosclerosis, there is continual recruitment of inflammatory monocytes, and the macrophages that differentiate from these monocytes in lesions may favour the classically activated (M1) subtype, which promote inflammation, over the alternatively activated (M2) subtype, which participate in inflammation resolution. Egress of inflammatory macrophages in advanced atherosclerotic lesions is also defective.Macrophage apoptosis coupled with defective clearance of these apoptotic cells (efferocytosis) in advanced atherosclerotic lesions is a particularly important process because it leads to the generation of plaque necrosis, which is a key feature of the types of atherosclerotic lesions that cause ATVD. One key mechanism of macrophage apoptosis in this setting is a pathway in which the endoplasmic reticulum stress pathway known as the unfolded protein response, perhaps in combination with pattern recognition receptor activation, triggers Ca2+-dependent apoptosis.The mechanisms of defective efferocytosis in advanced atheroma are not known, but may involve deficiency, dysfunction and/or competitive inhibition of receptors, ligands and other factors involved in apoptotic cell recognition and engulfment.The ability to translate the complex process of plaque progression into an integrated molecular and cellular concept of defective inflammation resolution provides a useful way to understand how atherosclerosis leads to clinical disease and how plaque progression may be prevented by new therapeutic approaches.

TRIM25-mediated XRCC1 ubiquitination accelerates atherosclerosis by inducing macrophage M1 polarization and programmed death

TRIM64 Promotes Ox-Ldl-induced Foam Cell Formation, Pyroptosis, and Inflammation in THP-1-derived Macrophages by Activating a Feedback Loop with NF-κB Via IκBα Ubiquitination.

Macrophages Promote Atherosclerosis Development by Inhibiting CD8T Cell Apoptosis

Macrophage-Derived GSDMD Plays an Essential Role in Atherosclerosis and Cross Talk Between Macrophages via the Mitochondria-STING-IRF3/NF-κB Axis

RNA Helicase DDX5 Participates in Oxldl-Induced Macrophage Scavenger Receptor 1 Expression by Suppressing Mrna Degradation

TRIM59 expression is regulated by Sp1 and Nrf1 in LPS-activated macrophages through JNK signaling pathway

Apoptotic cell induction of miR-10b in macrophages contributes to advanced atherosclerosis progression in ApoE-/- mice.

Macrophage Subsets and Death Are Responsible for Atherosclerotic Plaque Formation

TRIM21 aggravates cardiac injury after myocardial infarction by promoting M1 macrophage polarization

Silencing Triggering Receptors Expressed on Myeloid Cells-1 Impaired the Inflammatory Response to Oxidized Low-Density Lipoprotein in Macrophages

Macrophage Apoptosis and Efferocytosis in the Pathogenesis of Atherosclerosis

A Role of RIP3-Mediated Macrophage Necrosis in Atherosclerosis Development

Programmed death of macrophages in atherosclerosis: mechanisms and therapeutic targets

MicroRNA-216a Promotes M1 Macrophages Polarization and Atherosclerosis Progression by Activating Telomerase Via the Smad3/NF-κB Pathway.

Macrophage death and defective inflammation resolution in atherosclerosis

TRIM13 reduces cholesterol efflux and increases oxidized LDL uptake leading to foam cell formation and atherosclerosis

Activation of CD137 signaling promotes macrophage apoptosis dependent on p38 MAPK pathway-mediated mitochondrial fission

Toll-Like Receptor 7 Promotes The Apoptosis Of Thp-1-Derived Macrophages Through The Chop-Dependent Pathway

Oxidized Low-Density Lipoprotein Upregulates Microrna-146A Via JNK and NF-κB Signaling

Macrophage death in atherosclerosis: potential role in calcification

Bioinspired PROTAC-induced macrophage fate determination alleviates atherosclerosis